This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 101/10/1001    most recent CIRCRESAHA.107.160812v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Yang, X. P. Articles by Becker, L. C. Search for Related Content PubMed PubMed Citation Articles by Yang, X. P. Articles by Becker, L. C. Pubmed/NCBI databases Gene GEO Profiles HomoloGene UniGene Substance via MeSH Related Collections Signal transduction Oxidant stress Endothelium/vascular type/nitric oxide Other Vascular biology

(Circulation Research. 2007;101:1001.)
© 2007 American Heart Association, Inc.

Molecular Medicine

Fractalkine Upregulates Intercellular Adhesion Molecule-1 in Endothelial Cells Through CX3CR1 and the Jak–Stat5 Pathway

Xiao Ping Yang, Subhendra Mattagajasingh, Shaobo Su, Guibin Chen, Zheqing Cai, Karen Fox-Talbot, Kaikobad Irani, Lewis C. Becker

From the Cardiology Division, Department of Medicine (X.P.Y., Z.C., L.C.B.); Departments of Gynecology and Obstetrics (G.C.) and Pathology (K.F.-T.), Johns Hopkins University School of Medicine, Baltimore, Md; Cardiovascular Institute (S.M., K.I.), University of Pittsburgh, Pa; and Institute of Inflammation and Immune Diseases (S.S.), Shantou University Medical College, China.

Correspondence to Dr Lewis C. Becker, Cardiology Division, Halsted 500, Johns Hopkins Hospital, 600 N Wolfe St, Baltimore, MD 21287-5500. E-mail lbecker{at}mail.jhmi.edu

Fractalkine (FKN) is a membrane-bound chemokine that can be released by proteolysis to produce soluble FKN (s-FKN). FKN and its receptor, CX3CR1, are believed to be important factors in atherosclerosis and may play a role in acute inflammatory responses. Although FKN is expressed on endothelial cells (ECs), CX3CR1 is reported to reside mainly on certain leukocyte populations. RT-PCR and Western blotting demonstrated that both human coronary artery and umbilical vein ECs expressed CX3CR1 mRNA and protein. Confocal microscopy showed that CX3CR1 was located at the cell membrane and to a lesser extent in the cytoplasm. Following exposure of both types of ECs to hypoxia and reoxygenation, FKN expression increased rapidly and s-FKN was shed into the culture medium. The addition of s-FKN protein to cultured ECs resulted in a dose-dependent increase in intercellular adhesion molecule (ICAM)-1 mRNA. Perfusion of mouse hearts with s-FKN protein increased expression of ICAM-1 protein in vascular endothelium. Transfection of ECs with CX3CR1-interfering RNA to knockdown the receptor resulted in decreased ICAM-1 expression after s-FKN stimulation. In addition, when ECs were stimulated with s-FKN, greater adhesion of human neutrophils to the ECs was observed. This increase was ICAM-1 dependent and was blocked by CX3CR1 knockdown. Following exposure to s-FKN, ECs exhibited increased phosphorylation of Jak2 and Stat5 and the ICAM-1 expression induced by s-FKN was blocked by silencing of Stat5 with small interfering RNA. Vascular ECs express both FKN and its receptor CX3CR1. s-FKN is shed from ECs following hypoxia/reoxygenation and acts through CX3CR1 on ECs to increase ICAM-1 expression and promote neutrophil adhesion through activation of the Jak–Stat5 pathway.

Key Words: endothelial cell • CX3CR1 • fractalkine • adhesion • Stat5

This article has been cited by other articles:

				A. Zernecke, E. Shagdarsuren, and C. Weber Chemokines in Atherosclerosis: An Update Arterioscler. Thromb. Vasc. Biol., November 1, 2008; 28(11): 1897 - 1908. [Abstract] [Full Text] [PDF]